Story

ServiceNow Options Market Prices in 11% Post-Earnings Move

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
ServiceNow Options Market Prices in 11% Post-Earnings Move

Summary

Options traders are anticipating a potential 11% swing in ServiceNow (NYSE: NOW) shares following its July 22 earnings report, according to Bloomberg data. The stock has exceeded the options-implied move in three of the last eight quarters.

Text size
Background

The options market is pricing in a potential 11% swing in either direction for ServiceNow (NYSE: NOW) shares following the company's quarterly earnings report, scheduled for release on July 22. This figure, known as the implied move, reflects traders' expectations for significant volatility surrounding the announcement.

Market Expectations

According to options data compiled by Bloomberg, traders are positioning for a substantial price movement for the enterprise software company after it reports its results. The 11% implied move is derived from the pricing of at-the-money options contracts expiring after the earnings release, which is scheduled for after the market close on July 22.

This level of implied volatility suggests that investors are bracing for new information, such as revenue growth, profit margins, or forward guidance, that could materially impact the stock's valuation.

Historical Performance vs. Expectations

Sample IUX Markets – In-articleAd

An analysis of past earnings reports shows a mixed record of the stock's actual performance compared to market expectations. ServiceNow's shares have exceeded the options-implied move in three of the last eight earnings announcements, according to the data.

Key past movements include:

  • April 23, 2025: Shares jumped 15.0%, more than double the 7.0% implied move.
  • January 29, 2025: The stock fell 7.7%, slightly exceeding the 6.6% move priced in.
  • July 24, 2024: Shares rose 8.9%, significantly higher than the expected 5.8%.

Conversely, in more recent reports cited by the data, the stock's reaction was more muted than anticipated. On April 22, shares fell 3.4% against a 9.4% implied move, and on January 28, the stock dropped 6.9% versus a 7.5% expectation.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST